Categories: All postsAnalysts

Why Cisco Systems should be on your radar as an investor

David Dietze

Cisco Systems (Cisco Stock Quote, Chart, News: NASDAQ:CSCO) has fallen a long way down from its heady dot-com days, but the network hardware company still has a lot going for it, says David Dietze of Point View Wealth Management, who likes its solidly performing business model and attractive dividend.

Shares of Cisco Systems have been on the rise over the past two years, climbing over 70 per cent in value since early 2016. Still, at $44 and change (all figures in US dollars unless noted), the stock is a long way from its $82.00 high back in the year 2000 when the company boasted a market cap of over $500 billion.

“We didn’t like it almost a generation ago in 2000 when it was $84 a share, when there was no dividend and it was trading at 100x earnings,” Dietze told BNN. “Fast-forward 18 years here and it’s one of the fastest growing dividend payers out there, it has now an above-average yield, which is unusual, particularly in the tech group. The valuation is far more reasonable and they have a solid business.”

What Cisco lacks in growth, it seems to be making up in consistency, producing revenue and net income that have stayed in the $48 billion and $10 billion range, respectively, for the past four years. Its dividend yield currently sits at a healthy 3.02 per cent.

“There are some fierce competitors — the one that comes to mind is Arista Networks, which is really pushing them quite hard,” says Dietze. “Some of the key employees from Cisco went over there. It’s pushing them quite hard in their internet infrastructure businesses.”

“Basically, [Cisco’s] is old-line tech, it’s legacy tech,” says Dietze. “It’s a good position to have exposure to the area. It’s not going to be growing as fast as it did 20 years ago, but we still like it for the dividend.”

Tagged with: csco
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

WELL Health Technologies: this analyst just raised his price target

Paradigm Capital analyst Daniel Rosenberg says WELL Health Technologies’ (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) WELLSTAR… [Read More]

1 day ago

Datadog stock is undervalued, this investor says

Black Swan Dexteritas president and portfolio manager Kim Bolton says Datadog (Datadog Stock Quote, Chart, News, Analysts, Financials NASDAQ:DDOG) remains… [Read More]

1 day ago

TD Cowen launches coverage of Tecsys with a “Buy”

TD Cowen analyst John Shao says Tecsys’ (Tecsys Stock Quote, Chart, News, Analysts, Financials TSX:TCS) healthcare supply chain business gives… [Read More]

1 day ago

Buy Lantronix for a double, this analyst says

Roth Capital Partners analyst Scott Searle says Lantronix’s (Lantronix Stock Quote, Chart, News, Analysts, Financials NASDAQ:LTRX) acquisition of Vecima Networks’… [Read More]

2 days ago

This analyst just raised his price target on Maritime Launch Services

Beacon Securities analyst Russell Stanley says Maritime Launch Services’ (Maritime Launch Services Stock Quote, Chart, News, Analysts, Financials CSE:MAXQ) agreement… [Read More]

2 days ago

Air Canada was just upgraded by this analyst

National Bank Financial analyst Cameron Doerksen says Air Canada (Air Canada Stock Quote, Chart, News, Analysts, Financials TSX:AC) shares still… [Read More]

2 days ago